REQUEST FOR EXPRESSION OF INTEREST (REoI) FOR PHARMACEUTICAL PRODUCTS REOI-AFG-2024-002 Closing date for receipt of REoI:  Multiple windows of submissions due on 1st of every month open for 12 month starts on 1st July 2024 and ends on 1st June 2025. There are multiple due dates for submission: 1st of July 2024, 1st Aug 2024, 1st Sep 2024, 1st Oct 2024, 1st Nov 2024, 1st Dec 2024, 1st Jan 2025, 1st Feb 2025, 1st Mar 2025, 1st April 2025, 1st May 2025 and final due date 1st June 2025. UNICEF, Afghanistan Country Office, Kabul, Afghanistan is requesting Expressions of Interest from potential suppliers of pharmaceuticals from Afghanistan and its neighbouring countries (India, Iran, Pakistan, China, etc.) in preparation for a solicitation exercise for pharmaceutical products. Interested suppliers or manufacturers of pharmaceuticals, please read below the requirements and submit your expression of interest (EoI) by filling in the forms along with the documentation requested.   Purpose of the REOI:   This REoI is addressed to suppliers and manufacturers of pharmaceuticals in the region for the supply of any of the listed pharmaceutical products.   Description of requirements: Amoxicillin powder/oral suspension 125mg/5ml Amoxicillin 250mg dispersible tablet Amoxicillin 500mg tablet/capsule Chlorhexidine Digluconate gel 7.1 % for cord care Ciprofloxacin 250mg tablet Erythromycin powder for oral suspension 125mg/5ml Gentamicin eye drops 0.3% Micronutrient tabs, used during pregnancy. Salbutamol 2mg/5ml oral liquid Salbutamol 4mg tablets… tablets Salbutamol oral inhalation (aerosol) 0.1mg/ds 200ds Compound Sodium Lactate 1L bag/bottle Sodium Chloride 0.9 % w/v and Glucose 5% w/v solution, 500ml bag/bottle Ampicillin powder for injection 500mg For an itemised list of products per category, please refer to the accompanying Expression of Interest (EoI) form.